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In metazoans, proteins of the arrestin family are key players of G-protein-coupled receptors (GPCRS) signaling and traﬃcking.
Following stimulation, activated receptors are phosphorylated, thus allowing the binding of arrestins and hence an “arrest” of
receptor signaling. Arrestins act by uncoupling receptors from G proteins and contribute to the recruitment of endocytic proteins,
such as clathrin, to direct receptor traﬃcking into the endocytic pathway. Arrestins also serve as adaptor proteins by promoting
the recruitment of ubiquitin ligases and participate in the agonist-induced ubiquitylation of receptors, known to have impact on
their subcellular localization and stability. Recently, the arrestin family has expanded following the discovery of arrestin-related
proteins in other eukaryotes such as yeasts or fungi. Surprisingly, most of these proteins are also involved in the ubiquitylation and
endocytosis of plasma membrane proteins, thus suggesting that the role of arrestins as ubiquitin ligase adaptors is at the core of
these proteins’ functions. Importantly, arrestins are themselves ubiquitylated, and this modification is crucial for their function.
In this paper, we discuss recent data on the intricate connections between arrestins and the ubiquitin pathway in the control of
endocytosis.
1. Introduction
The name of “arrestin” was initially given to a 48-kDa
protein that was essential to “arrest” the signal following
the photoexcitation of rhodopsin, a photoreceptor of the G-
protein-coupled receptors (GPCRS) family expressed in rod
and cone cells of the retina [1, 2]. A second isoform involved
in the same process has later been identified; both of these
proteins are now designated visual arrestins (or arrestin-1
and -4) (for review see [3]). A similar regulatory system was
described for another GPCR, the β2-adrenergic receptor (β2-
AR), which involves two other arrestins, named β-arrestin-
1 and -2 (or arrestin-2 and -3, resp.) [4–6]. β-arrestins are
ubiquitously expressed and were later found to regulate a
large number of receptors in addition to β2-AR.
2. Arrestin-Mediated Regulation of GPCRs
2.1. Arrestin-Dependent Uncoupling of GPCRs from G-
Proteins. Arrestins are key players in the regulation of
GPCR signaling activity. Upon agonist stimulation, GPCRs
undergo conformational changes leading to their association
to heterotrimeric G proteins and subsequent activation,
thereby triggering appropriate signal transduction pathways.
Receptor desensitization is initiated after ligand binding
through the phosphorylation of residues within their cytoso-
lic loops by G-protein-coupled receptor kinases (GRKs). This
modification allows arrestin docking to the GPCR, which
in turn favors the uncoupling between the receptor and the
G protein. Indeed, β-arrestins are cytosolic proteins that,
in response to receptor stimulation, relocalize rapidly to
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the plasma membrane [7]. Structural and structure-function
studies of visual arrestins identified a phosphate-sensor
domain in the polar core of the protein [8]. Intramolecular
interactions between the C-terminal tail and the phosphate
sensor region maintain the arrestin in an inactive state,
and this interaction is disrupted upon binding to the
phosphorylated receptor. This interaction is followed by a
conformational change of the arrestin molecule and leads to
a high-aﬃnity receptor-binding state. Arrestin recruitment
onto the phosphorylated receptor hinders its interaction with
G protein, and consequently silences the activation of the
GPCR-G protein-signaling module.
2.2. Arrestins and GPCR Endocytosis. Another crucial com-
ponent of GPCR regulation operates at the level of their
localization [9]. Endocytosis plays a major role in the
modulation of GPCR signaling activity, and, again, this
regulation involves β-arrestins [10]. Indeed, β-arrestins act
as endocytic adaptor proteins that recruit components of
the endocytosis machinery to promote GPCR internaliza-
tion and/or degradation. β-arrestins interact with clathrin
through a clathrin-binding motif [11–13] to promote GPCR
association to clathrin-coated pits (CCPs). Deletion of the
clathrin-binding site abrogates arrestin-promoted traﬃcking
of the β2-AR [14]. Additionally, β-arrestins interact with the
clathrin adaptor complex AP-2 uponGPCR binding [14–16],
to promote clathrin-coat assembly and receptor targeting to
CCPs [17]. In addition to clathrin, β-arrestins also bind to
other components of the endocytic machinery such as the
N-ethylmaleimide-sensitive fusion protein (NSF), the small
G protein ARF6, and the phosphatidylinositol 4-phosphate
5 kinase PIP5K Iα [18–20].
2.3. Arrestins as Signaling Scaﬀolds. Besides their functions
in GPCR desensitization and traﬃcking, β-arrestins are
also capable of generating their own signals by scaﬀolding
signaling molecules, such as non-receptor tyrosine kinases
of the Src family, or MAP (mitogen-activated protein)
kinases (ERK1/2, c-Jun N-terminal kinase 3 JNK3) (reviewed
in [21]). β-arrestins therefore mediate a second wave of
signaling distinct from G-protein-dependent signaling.
2.4. Arrestins and Ubiquitin. β-arrestins were also shown
to regulate the final fate of the receptor, by acting on
the balance between receptor recycling to the plasma
membrane, or its lysosomal degradation. The posttransla-
tional modification of plasma membrane proteins, including
receptors, by ubiquitin is known to aﬀect their sorting
along the endocytic pathway [22, 23]. β-arrestins have the
ability to recruit ubiquitin ligases and promote receptor
ubiquitylation, therefore acting as “adaptor” proteins [24].
Interestingly, a phylogenetic study has revealed that proteins
of the arrestin family are present in all eukaryotes, except
plants [25, 26]. A body of evidence (detailed later in this
review, [27]) indicates that these arrestin-related proteins are
also involved in the regulation of plasma membrane proteins
traﬃcking by acting as ubiquitin ligase adaptors. Therefore,
this function seems to be one of the most conserved features
within the arrestin family [28, 29].
Both arrestins and arrestin-related proteins are them-
selves targets of ubiquitylation. This was discovered very
early on for β-Arr2 in response to agonist stimulation
[30]. Likewise, the fungal arrestin-related protein PalF was
shown to be ubiquitylated in response to alkaline ambient
pH, in a signal- and receptor- (PalH) dependent manner
[31]. This ubiquitylation appeared crucial for the proper
function of arrestins [24, 32–35], but the precise role
of this modification is poorly understood. An additional
layer of complexity has recently been added following the
observations that β-arrestins interact with deubiquitylating
enzymes that regulate their ubiquitylation status as well as
receptor ubiquitylation and, consequently, their fate [35–37].
In this review, we will focus on the connections between
arrestins and ubiquitin. We will detail the function of
arrestins and arrestin-related proteins as ubiquitin ligase
adaptor and discuss how arrestin functions could be regu-
lated by ubiquitylation.
3. Arrestins as Ubiquitin Ligase Adaptors
3.1. Ubiquitin and Endocytic Protein Sorting. Studies in
the last decades have shown that ubiquitin is a master
regulator of endocytosis in eukaryotes. Early work performed
in the yeast Saccharomyces cerevisiae demonstrated that
ubiquitin is involved in the endocytosis of plasmamembrane
proteins, such as ABC (ATP-binding cassette) transporters
[38], receptor[39, 40], or permeases [41]. The ubiquitylation
of plasma membrane proteins appears to trigger their
internalization and targeting to endosomes [42], although
the existence of an ubiquitin-independent internalization
mechanism is also documented [43]. In mammalian cells,
the situation is more complex, as several internalization
pathways exist in the cell with only some of them regulated
by ubiquitin [44].
Initially, it has been proposed that ubiquitylated cargoes
are recognized in yeast and mammals by the ubiquitin-
binding motifs of various proteins involved in endocytosis,
such as Eps15 (Ede1 in yeast) and Epsin (Eps15 interacting;
Ent1 and Ent2 in yeast) which display UIM (ubiquitin-
interacting motif) or UBA (ubiquitin-associated) domains
[45, 46]. In addition, these endocytic proteins can also
interact with phosphoinositides and clathrin, making them
ideal candidates to coordinate ubiquitin recognition and
cargo internalization. While such a function appears to
be established in mammalian cells [47–49], recent data
in yeast favor a more complex model, where ubiquitin-
binding domains would play a more general role in protein
interactions and the assembly of the endocytic network
[50]. Noteworthy, in mammalian cells, endocytic adaptors
are often ubiquitylated in response to extracellular stimuli,
and this contributes greatly to the ubiquitin-based signaling
triggered upon cell stimulation [23, 51–53].
A second major ubiquitin-dependent step in the endo-
cytic pathway occurs at multivesicular bodies (MVBs) and
is required for cargo delivery into lysosomes [54]. Cargo
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ubiquitylation provides the crucial signal for entering into
this pathway. A series of protein complexes, collectively
named ESCRT (endosomal sorting complex required for
transport) carry ubiquitin-binding domains and act in
concert to allow the recognition and sorting of ubiquitylated
cargoes into luminal vesicles ofMVBs [55]. Therefore, lack of
cargo ubiquitylation at this stage leads to a defective targeting
to the lysosome, and, eventually, recycling [56].
In mammalian cells, initial studies showed that the
ubiquitin conjugation system is important for the downregu-
lation of the growth hormone receptor (GHR) [57]. Also, the
study of the amiloride-sensitive epithelial sodium channel
ENaC clearly established that its ubiquitylation regulates the
channel’s stability [58]. Subsequent work on ENaC, GHR,
and many other receptors (such as EGFR, PDGFR, c-Met,
TGF-βR, β2-AR) confirmed the critical function of ubiquitin
in endocytosis in mammals [23, 59, 60]. However, where
this ubiquitylation occurs in the cell (plasma membrane or
endosomal compartments), and how ubiquitylation impacts
on the target receptor’s fate (internalization, progression
through the endocytic pathway, or degradation) are still
a matter of debate and seem to vary upon the receptor
and the physiological situation considered [61]. Also, it
should be noted that while ubiquitin-mediated endocytosis
appears as the main pathway in yeast, ubiquitin-independent
endocytosis is more represented in higher eukaryotes [44,
62].
3.2. The “Classic” β-Arr2/β2-AR Couple. A first evidence
for the role of arrestins in receptor ubiquitylation came
from a study by Shenoy and colleagues who observed that
the β2-AR is ubiquitylated within 15min of isoproterenol
stimulation, ultimately leading to receptor degradation [30].
β2-AR ubiquitylation requires β-Arr2 and the ubiquitin
ligase MDM2, which turned out to ubiquitylate β-Arr2
rather than β2-AR (see below) [30]. A mutant β2-AR lacking
the ubiquitylation sites (β2− ARK0) is normally internalized,
but not degraded [30]. In contrast, a translational fusion
of ubiquitin to the β2-AR, which mimics its constitutive
ubiquitylation, is internalized similarly as the wild-type β2-
AR, but is degraded more eﬃciently [24].
Therefore, ubiquitylation is a critical signal for β2-
AR degradation upon stimulation. A similar implication
of GPCR ubiquitylation in its degradation, but not in its
internalization, was also reported in the case of CXCR4 [63].
The identity of the ubiquitin ligase responsible for β2-AR
ubiquitylation was revealed more recently. Indeed, β-Arr2
was found to interact with the HECT-type (homologous
to E6-AP C-terminus) ubiquitin ligase Nedd4 (discussed
below in this paper). Nedd4 (neural precursor cell expressed
developmentally downregulated protein 4) promotes β2-
AR ubiquitylation at endosomes, leading to its lysosomal
targeting [24].
Once internalized, GPCRs can also escape degradation
and recycle back to the plasma membrane in a functional
state to mediate further signaling. Because GPCR ubiqui-
tylation appears to trigger its degradation, deubiquitylation
could regulate GPCR recycling to the plasma membrane.
Indeed, two deubiquitylating enzymes named USP33 and
USP20 regulate β2-AR deubiquitylation, recycling and resen-
sitization [35, 37]. USP33 was first identified as a β-arrestin
interactant, thus suggesting that β-Arr2 could be involved
in USP33 recruitment to β2-AR [35]. However, USP33
was found to interact with β2-AR even before agonist
stimulation, that is, when β-Arr2 is not yet translocated
to the plasma membrane [37]. In fact, USP33 appears
to be transferred from agonist-activated β2-AR to β-Arr2,
thus triggering its deubiquitylation and dissociation from
the receptor, once internalized. Reassociation of USP33
with β2-AR in endosomal compartments would regulate its
deubiquitylation and recycling to the plasma membrane.
Thus, the association and dissociation of β-Arr2 from β2-
AR may coordinate the ubiquitin conjugating/deconjugating
activities towards β2-AR to tune the balance between recep-
tor degradation and recycling. This positions the ubiquitin
ligase adaptor function of β-Arr2 as a key regulator of GPCR
signaling.
3.3. β-Arrestins as Ubiquitin Ligase Adaptors: Other Examples.
The function of β-arrestins as ubiquitin ligase adaptors is
not restricted to β2-AR. Additional studies identified β-
arrestins as ubiquitin ligase adaptors for non-GPCR proteins:
β-Arr1, as β-Arr2, acts as an adaptor for ubiquitin ligases of
the Nedd4 family such as Itch/AIP4 (Atrophin-1-interacting
protein 4) for ubiquitylation of the TRPV4 (transient
receptor potential) channel [64], and Nedd4 for that of the
Na+/H+ exchanger 1 (NHE1) [65]. In the latter case, how-
ever, and in contrast to the situation described for the β2-
AR, cargo ubiquitylation is required for its internalization.
Because β-arrestins interact with both ubiquitin ligase and
clathrin (see above), they may then act at two levels: first,
for cargo ubiquitylation, which could recruit Eps15/Epsin
endocytic adaptors, and, second, to assist the latter in the
recruitment of a clathrin coat.
The contribution of β-arrestins to the traﬃcking of
another classical GPCR, the chemokine receptor, CXCR4,
was also studied. Early reports had shown that the ligand-
induced ubiquitylation of CXCR4 by the Nedd4-like ubiqui-
tin ligase AIP4 is required for its lysosomal sorting [63, 66].
β-Arr1 interacts with AIP4 at endosomes, and knockdown
experiments revealed that β-Arr1 is an important player in
CXCR4 degradation but, surprisingly, is not required for
its ubiquitylation [67]. Instead, CXCR4 is phosphorylated
at the plasma membrane after ligand binding, which allows
the direct recruitment of the ubiquitin ligase AIP4 via its
WW domains, and hence CXCR4 ubiquitylation [68]. β-
Arr1 was later found to interact with the ESCRT-0 complex
and to direct the ubiquitylation of one of its components,
HRS (hepatocyte growth factor-regulated tyrosine kinase
substrate) in a CXCR4-dependent manner [69].
Interestingly, β-arrestins appear to act primarily as
adaptors for ubiquitin ligase of the Nedd4 family. These
enzymes display WW domains that can interact with specific
proline-richmotifs (usually, a [L/P]PxY sequence). Although
this motif is sometimes present on the targeted substrates,
as in the case of ENaC [70], in most cases this interaction
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motif is present on an adaptor protein in charge of substrate
recognition [71]. However, no PPxY motif has been found
in β-arrestins, and polyproline regions are not involved in
Nedd4 interaction [24]. In addition, Nedd4 recruitment
to β2-AR was not aﬀected by mutations in Nedd4 WW
domains. This indicates that this interaction involves a
noncanonical binding of β-Arr2 to Nedd4, for which the
molecular determinants remain to be addressed.
In some cases, β-arrestins act as adaptors for ubiquitin
ligase which do not belong to the Nedd4 family. β-Arr1
was proposed to act as an adaptor for the RING (Really
interesting new gene) ubiquitin ligase Mdm2 to mediate
insulin-like growth factor I (IGF-1) receptor ubiquitylation
and downregulation [72, 73]. A similar role was appointed to
β-Arr2 for the ubiquitylation of the androgen receptor [74].
Again, the molecular basis of this interaction awaits further
investigations.
4. Arrestin-Related Proteins:
New Players in the Field
Visual and β-arrestins share a similar structure, with an
arrestin fold in their N-terminal domains and a C-terminal
tail [75–80]. It was proposed that visual and β-arrestins
actually originate from an ancestral arrestin family from
which they diverged relatively recently [25]. This ances-
tral family would also have given rise to proteins whose
expression is not limited to metazoans: members of the
Vps26 family, which display an arrestin-like fold [81, 82],
as well as arrestin-related proteins (also coined α-arrestins)
[25]. Indeed, proteins displaying sequence homologies to
arrestins were first identified in the filamentous fungus
Aspergillus nidulans, named CreD [83] and PalF [31], and
more recent work in yeast allowed to identify additional
members of this protein family renamed “ART” (arrestin-
related traﬃcking adaptors) [34, 84, 85] that will be discussed
later in this paper. In human, the ART family is composed
of six members, named arrestin-domain containing 1–5
(ARRDC1–5) and TXNIP (Thioredoxin-interacting protein)
(Figure 1). Therefore, arrestin-related proteins are expressed
in all eukaryotes, except plants, which interestingly do not
harbor Nedd4-like genes either [25].
4.1. Arrestin-Related Proteins as Endocytic Adaptors. A main
diﬀerence between visual/β-arrestins and arrestin-related
proteins is that the latter possess PPxY motifs (Figure 1).
In agreement with the reported function of these motifs
(see above), many studies have documented the ability
of yeast arrestin-related proteins to interact with the only
Nedd4-like ubiquitin ligase in S. cerevisiae, named Rsp5
[33, 34, 85–90]. Rsp5 is critical for ubiquitin-dependent
intracellular traﬃcking pathways, such as endocytosis and
MVB sorting [91]. However, most of the transporters lack
PPxY motifs, and until recently, the molecular basis for the
interaction between Rsp5 and transporters was unknown.
It has become clear that yeast arrestin-related proteins
fulfill this function, by acting as Rsp5 adaptors to mediate
ubiquitylation and subsequent endocytosis of transporters
[33, 34, 84, 85, 90]. Using a chemical-genetic screen, Emr
and colleagues have identified Ldb19/Art1 as a regulator
of the endocytosis of Can1, an arginine transporter [34].
The function of Ldb19/Art1 was also extended to the
endocytosis of other amino acid transporters. In a parallel
study, Nikko et al. showed that two other arrestin-related
proteins, named Ecm21/Art2 and Csr2/Art8, are specifically
involved in the downregulation of themanganese transporter
Smf1 [85]. Altogether, around 10 arrestin-related proteins
were identified in yeast [34, 84, 85], and gathered in a family
referred to as “ART” (arrestin-related traﬃcking adaptors).
Contrary to the situation in mammalian cells, where β-
arrestins mainly act at a late step in cargo sorting, studies in
yeast suggested a role for arrestin-related proteins in cargo
internalization at the plasmamembrane [27]. Indeed, several
yeast ARTs are involved in the signal-induced internalization
of transporters in response to specific environmental signals
[33, 34, 84, 85, 90]. In addition, Art1 relocalizes to the plasma
membrane in response to the signal that induces amino acid
transporter endocytosis [34, 92].
However, as for β-arrestins, the situation is probably
more complex, and the role of ARTs in endocytosis may
not be restricted to the plasma membrane. In the course of
their study of the high-aﬃnity iron-uptake protein complex
Fet3/Ftr1 in yeast, Burd and colleagues documented an
example of ubiquitin-independent internalization [43]. The
results show that a nonubiquitylatable form of Fet3/Ftr1
can still be internalized but is constitutively recycled back
to the plasma membrane, leading to an apparent defect
in internalization. Although the involvement of an arrestin
remains to be determined, it strongly suggests that in this
system, cargo ubiquitylation by Rsp5 is required at endo-
somal compartments, rather than at the plasma membrane.
In addition, two yeast arrestin-related proteins, Aly1/Art6
and Aly2/Art3, have been shown to localize to intracellular
compartments and to control the traﬃcking of the general
amino-acids transporter Gap1 between trans-Golgi and
endosomes [93]. Consistent with these findings, Aly1 and
Aly2 interact with both clathrin and Golgi-specific clathrin
adaptor complex AP-1, thus suggesting that arrestin related
proteins, as β-arrestins, promote clathrin-coat assembly and
cargo targeting to clathrin-coated vesicles. Therefore, futures
studies will be necessary to precise where yeast arrestin-
related proteins act on cargo traﬃcking. Regarding their
intracellular localizations, we can already hypothesize several
modes of action within the ART family of proteins.
Like their yeast homologs, several human ARRDC
proteins are able to interact with ubiquitin ligases of
the Nedd4 family [94–97]. Among those, ARRDC3 was
isolated in a screen designed to identify proteins involved
in β2-AR ubiquitylation and degradation after agonist
treatment [95]. ARRDC3, as β-Arr2 [24], was shown
to bridge the interaction between Nedd4 and β2-AR,
leading to the intriguing possibility that arrestin-related
proteins might coordinate, together with β-arrestins,
receptor ubiquitylation and degradation. Because both
classes of arrestins have the ability to dimerize [94, 98],
this raises the possibility of potential heterooligomers
between arrestin and arrestin-related proteins that
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Figure 1: Schematic representation of the domain organization of human arrestins and arrestin-domain containing (ARRDC) proteins, and
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could reveal a complementary role between arrestin
classes.
The basic function of arrestin-related proteins as ubiq-
uitin ligase adaptor therefore seems strongly conserved. Of
note, a role for ARRDC3 in the degradation of a cell surface
adhesion molecule, integrin β4, was also pointed out, but its
role as ubiquitin ligase adaptor in this context has not been
investigated [99]. Future studies will indubitably unravel new
connections between ubiquitin and arrestin-related proteins.
4.2. Other Functions of Arrestin-Related Proteins: An ESCRT
Connection. As previously mentioned, arrestin-related pro-
teins were initially identified in A. nidulans and named CreD
[83] and PalF [31]. Interestingly, in both cases, a connection
with the ubiquitin pathway was established. CreD was shown
to interact physically with the Nedd4 homologue in A.
nidulans, HulA, whereas PalF was found to be ubiquitylated
in vivo. PalF, a protein involved in the ambient pH signaling
in fungi, binds to the seven-transmembrane and putative
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pH sensor, PalH. This pointed out to many similarities
between mammalian β-arrestins and this arrestin-related
protein [31].
As in A. nidulans, the yeast PalF homologue Rim8/Art9 is
essential for the proteolytic activation of the pH-responsive
transcription factor, Rim101, in response to neutral-alkaline
pH [100]. Interestingly, there is an intricate connection
between the ESCRT machinery, involved in ubiquitin-
dependent cargo sorting at the MVB, and this signaling
pathway [100–102]. The ART Rim8/Art9 is central to
the coordination of the ESCRT machinery and the pH-
signaling pathway, as it interacts with both the putative
pH sensor Rim21 and the ESCRT-I subunit Vps23 [89].
ESCRT appears to provide a platform for recruitment of a
protein complex containing the ESCRT-III binding protein
and ALIX homologue Rim20, that enables the proteolytic
activation of the Rim101 transcription factor in response
to the pH signal. Although initial studies suggested that
this process takes place at the endosomal membrane [103],
subsequent work supported the idea that arrestin-mediated
recruitment of ESCRT in the fungal ambient pH signaling
pathway may occur at the plasma membrane [89, 104].
Similarly, some of the human ARRDCs interact with the
Vps23 homologue TSG101 or the ESCRT-associated protein
ALIX [90, 96]. In particular, ARRDC1-mediated recruitment
of ESCRT appears to drive the formation of microvesicles at
the plasma membrane that may be involved in intercellular
communication [94, 105]. Interestingly, this situation is
reminiscent of the budding step of diﬀerent enveloped RNA
viruses, which recruit ESCRT components through similar
interactions to promote membrane scission and subsequent
viral particle release [106]. Accordingly, overexpression of
several ARRDCs inhibits murine leukemia virus (MLV)
viral particle release in a PPxY-specific way [96]. Therefore,
ARRDCs may act as adaptors between Nedd4-like enzymes
and the ESCRT machinery, in viral budding.
Finally, the connection between arrestin and the ESCRT
machinery may not be restricted to arrestin-related pro-
teins. Indeed, and as previously mentioned, β-Arr1 was
found to interact with STAM-1 (signal-transducing adaptor
molecule), a component of ESCRT-0, to regulate endosomal
sorting of CXCR4 [69].
5. Regulation of Arrestin Function by Ubiquitin
5.1. Regulation of β-Arrestins by Ubiquitylation. Arrestins
are specifically recruited to the cargoes following agonist
stimulation (receptor) or in response to the presence of the
substrate (transporter, channel), thus suggesting that they
are regulated to mediate an adapted response of the cell to
extracellular changes.
As mentioned previously, Shenoy and colleagues showed
in a seminal article that β-Arr2 is itself ubiquitylated in
response to agonist treatment [30]. Ubiquitylation of β-
Arr2, in contrast to that of β2-AR, does not require Nedd4,
but an ubiquitin ligase of the RING family, Mdm2. As this
modification occurred upon stimulation, this suggested a
role for β-Arr2 ubiquitylation in β-AR traﬃcking. Indeed,
Mdm2 knockdown caused a defect in β2-AR internalization.
Thus, β-Arr2 ubiquitylation appears to play a key role in
GPCR traﬃcking, and several lines of evidences support this
idea.
To address directly the importance of this posttransla-
tional modification and to avoid potential indirect eﬀects
of the knockdown of the Mdm2 ubiquitin ligase on
β2-AR traﬃcking, studies were performed using both a
nonubiquitylatable mutant form of β-Arr2 (β − Arr20K)
and a translational fusion of ubiquitin to β-Arr2 (β-Arr2-
Ub) [107]. These experiments showed that β − Arr20K
recruitment to the plasma membrane was only transient
and unable to trigger internalization of β2-AR. On the
opposite, translational fusion of ubiquitin to β-Arr2 led to
its co-traﬃcking with β2-AR into endosomal compartments
[107]. Previous observations had classified GPCRs in two
classes (A and B), based on the interaction pattern between
receptor and β-arrestin. Interaction of β-arrestin with class
A receptors (e.g., β2-AR) only takes place at the plasma
membrane, while its interaction with class B receptors (e.g.,
angiotensin II type 1a receptor: AT1aR, or vasopressin V2
receptor: V2R) is more stable and persists even after receptor
internalization [108]. Interestingly, the increased stability
of the interaction between class B receptors and β-arrestin
correlates with a sustained β-arrestin ubiquitylation, which
is not observed with class A receptors [36]. Indeed, even
if β − Arr2K0 is able to interact with the receptor in vitro,
this interaction is weaker than that displayed with the wild
type form in vivo. On the opposite, translational fusion of
ubiquitin to β-Arr2 displays a stronger binding than wild
type β-Arr2 [107]. β-Arr2 ubiquitylation therefore appears
to reinforce the interaction with β2-AR.
Because β-Arr2 is capable of interacting with the endo-
cytic machinery, such as clathrin or clathrin adaptors, the
failure of β− Arr2K0 to promote β2-AR internalization
could originate from an impaired interaction with these
components. Indeed, β − Arr2K0 exhibits a weaker inter-
action with clathrin than the wild-type form [107]. While
clathrin is not known to interact with ubiquitin, β-Arr2
ubiquitylation might stabilize the interaction with clathrin
through other components of the endocytic machinery such
as Eps15/epsin proteins that are able to bind both ubiquitin
and clathrin.
β-Arr2 ubiquitylation was also shown to aﬀect its
scaﬀolding function for signaling proteins. The amplitude of
β-arrestin-mediated activation of ERK (extracellular signal-
regulated kinase) correlates with the β-Arr2 ubiquitylation
status. Although β-Arr2 ubiquitylation was not required
for its interaction with MAP kinases (such as c-Raf and
ERK), translational fusion of ubiquitin to β-Arr2 led to
an increased level of ERK activity in endosome localized
receptor complexes (signalosomes). Consistent with these
findings, β-arrestin ubiquitylation promote its association
withmembrane. Again, ubiquitylation appears to function in
stabilizing the β-arrestin-mediated interaction between the
receptor and signaling proteins [107].
Finally, arrestins undergo conformational changes upon
binding to activated receptors [109]. Ubiquitin modification
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could therefore contribute to the proper rearrangement of
the β-arrestin structure, leading to optimal interactions with
its partners, and this awaits further investigations.
5.2. Regulation of Arrestin-Related Protein by Ubiquitylation.
Many arrestin-related proteins have also been reported as
substrates for ubiquitylation, both in fungi and human
[31, 33, 34, 89, 90, 94, 96, 97, 110]. Ubiquitylation of these
proteins, in contrast to that of β-arrestins, is triggered by
ubiquitin ligases of the Nedd4 family. Therefore, arrestin-
related proteins are adaptors as well as targets of the same
ubiquitin ligases.
The yeast arrestin-related protein Ldb19/Art1 is required
for the endocytosis of amino acid permeases, such as the
arginine transporter, Can1. Failure to endocytose Can1 leads
to sensitivity of the cells to canavanine, a toxic analog
of arginine. A nonubiquitylatable mutant of Ldb19/Art1
cannot grow on this drug, suggesting that Can1 remains at
the plasma and therefore that Art1 is not functional [34].
The importance of ubiquitylation for ART function was
also demonstrated for Rod1/Art4, involved in the glucose-
induced endocytosis of carbon sources transporters [33,
84]. Rod1/Art4 is ubiquitylated in response to glucose
exposure and a nonubiquitylatable mutant is unable to
promote the endocytosis of the lactate transporter, Jen1,
following glucose treatment [33]. Altogether, these data
indicate that ART ubiquitylation is crucial for their function
in endocytosis. Human arrestin-related protein ARRDC3
was isolated in a screen designed to identify genes involved
in β2-AR degradation, and acts as a Nedd4 adaptor for β2-
AR ubiquitylation [95]. While ARRDC3 ubiquitylation has
not yet been observed, ARRDC1 and TXNIP were shown
to be ubiquitylated by ubiquitin ligases of the Nedd4 family
[90, 96, 97]. Thus, it is tempting to speculate that the same
regulation applies in fungi and human.
The ubiquitylation of the arrestin-related protein PalF
in A. nidulans is triggered in a signal-(alkaline pH) and
receptor-(PalH) dependent manner [31]. PalF ubiquitylation
appears as a major determinant of its activity, since the
translational fusion of ubiquitin to PalF leads to a con-
stitutive activation of the pathway [110]. The yeast PalF
homologue Rim8/Art9 was shown to be monoubiquitylated
[89]. Monoubiquitylation of Rim8/Art9 occurs on a lysine
residue in its C-terminus and, as for all other ARTs described
to date in yeast, is performed by Rsp5, which binds to a PxY
motif near the ubiquitylation site. This monoubiquitylated
residue, together with a SxP motif, contributes to the inter-
action of Rim8/Art9 with the ESCRT-I subunit Vps23 via its
ubiquitin-binding domain, UEV (ubiquitin E2 variant) [89].
Interestingly, Vps23 binding appears to control the levels
of monoubiquitylated Rim8/Art9, thus suggesting that this
interaction either promotes Rim8 ubiquitylation or prevents
its further polyubiquitylation and possibly its degradation.
Interaction of human ARRDC1 with the Vps23 homologue
Tsg101 was shown to be mediated by a PSAP motif which,
like the SxP motif in Rim8, is located at the protein C-
terminus [94, 96]. In addition, it was proposed that the
ubiquitylation of ARRDC1 is important for its function [94].
However, this is based on results obtained upon depletion
of the corresponding Nedd4-like ligase WWP1, which in
principle could also impair a potential adaptor function and
may have oﬀ-target eﬀects. Therefore, the identification and
mutation of the ubiquitylation sites will be critical to address
this question.
5.3. Dynamic Regulation of Arrestin Ubiquitylation.
Phosphorylation-Dependent Ubiquitylation? Because
ubiquitin ligases target a large number of proteins in
the cell, their activity toward a given substrate is usually
indirectly regulated through substrate accessibility, either
by the use of adaptor proteins, or by post-translational
modification of the substrate, such as phosphorylation
[111].
Interestingly, cytosolic β-arrestins are constitutively
phosphorylated, and undergo dephosphorylation upon
binding to the activated receptor. β-Arr1 dephosphoryla-
tion is required for β2-AR internalization, but not for its
desensitization [112]. Indeed, a β-Arr1 mutant mimicking
constitutive phosphorylation displays a weaker interaction
with clathrin but an unaltered β2-AR binding [112]. Similar
data were reported for β-Arr2, and the phosphorylation
site was localized near the clathrin and AP-2 binding
motifs, thus providing an explanation as to why β-Arr2
phosphorylation regulates the interaction with clathrin/AP-2
[113]. Additionally, the phosphorylation of the major visual
arrestin in Drosophila (Arr2) also regulates its interaction
with clathrin [114].
Importantly, once the receptor is internalized, β-
Arr1 is rephosphorylated. These dynamic phosphoryla-
tion/dephosphorylation events suggest the involvement of
kinases and phosphatases whose activation is coordinated
in response to agonist exposure. Interestingly, β-Arr1 is
phosphorylated in vitro by ERK kinases and accordingly,
the modulation of ERK activity in vivo aﬀects β-Arr1
phosphorylation, thus providing an inhibitory feedback
control of its function [115].
Although β-arrestins are both dephosphorylated and
ubiquitylated upon receptor binding, an eventual rela-
tionship between these two modifications remained to be
addressed. Such a link has been described for the yeast
arrestin-related protein Rod1/Art4, involved in the glucose-
induced endocytosis of carbon sources transporters [33]. As
for β-arrestins, Rod1/Art4 dephosphorylation and ubiquity-
lation occurs in response to an external signal-in this case,
glucose. The yeast homologue of AMPK (5
′
-AMP-activated
protein kinase), Snf1, and its counteracting phosphatase PP1
(protein phosphatase 1) control the phosphorylation status
of Art4/Rod1 in response to glucose availability. Therefore,
in the absence of glucose, Art4/Rod1 is phosphorylated and
endocytosis is inhibited. This inhibitory eﬀect results from
the ability of phosphorylated Art4/Rod1 to bind 14-3-3
proteins, thereby hindering its ubiquitylation by Rsp5 and
hence preventing its activation [33].
Interestingly, phosphorylation of another yeast arrestin-
related protein, Ldb19/Art1, also regulates its function.
A recent study indicated that Ldb19/Art1 is subject to
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phosphoinhibition through the action of the TOR (target of
rapamycin) eﬀector and protein kinase Npr1, thus allowing
cells to regulate amino acid transporter endocytosis in
response to the nitrogen status [92]. While the overall
phospho-inhibition mechanism recalls that of Rod1/Art4,
Ldb19/Art1 ubiquitylation is uncoupled from its phospho-
rylation, suggesting a diﬀerent regulatory mechanism [34].
The identification of Npr1-dependent phosphorylation sites
on Ldb19/Art1 allowed generating a nonphosphorylatable
mutant form of the protein. Interestingly, this mutant fails
to be translocated at the plasma membrane upon stimu-
lation, which likely explains why transporters endocytosis
is impaired [92]. Further work will be needed to under-
stand the molecular mechanism of this phosphorylation-
dependent inhibition.
Other examples of arrestin-related proteins that are
subjected to phosphorylation which include A. nidulans PalF,
involved in ambient pH sensing, although the regulatory
mechanism appears to be diﬀerent since PalF undergoes
phosphorylation instead of dephosphorylation, in response
to the ambient pH signal [31]. The same result has been
observed in the pathogenic yeast Candida albicans, where the
PalF homologue Rim8 is also phosphorylated in response
to neutral-alkaline pH [116]. Although phosphorylation
of Rim8/Art9 in baker’s yeast has not been reported, its
ubiquitylation does not appear to be regulated by ambient
pH, in contrast to that of PalF, which is induced by alkaline
pH [89]. The apparent lack of regulation of Rim8/Art9
ubiquitylation is consistent with its role in Vps23 binding,
which appears to occur even in nonstimulated conditions.
Thus, the pH-dependent regulation of PalF ubiquitylation in
A. nidulans may reflect an additional level of regulation in
this organism.
From these studies, it emerges that arrestin-related
proteins are often modified posttranslationally in response
to stimulation, either by phosphorylation, ubiquitylation, or
both. A crosstalk between phosphorylation and ubiquityla-
tion has been evidenced. How these modifications operate to
coordinate arrestin function is unknown, and this provides
new avenues for research in this field.
Ubiquitylation and deubiquitylation.Ubiquitylation, akin
to phosphorylation, is a reversible process. Therefore,
deubiquitylation appeared as a possible mechanism for
regulation of arrestin function. In support of this idea,
the transient β-Arr2 ubiquitylation associated to class A
receptor suggested that deubiquitylation occurs rapidly after
agonist stimulation. Indeed, the ubiquitin-specific protease
33 (USP33) was shown to deubiquitylate β-Arr2 following
β2-AR binding [35]. USP33 knock-down led to an increase
in β-Arr2 ubiquitylation. This was accompanied by a
stronger interaction with the receptor, and a prolonged
β-Arr2-dependent MAP kinase signaling. These findings
are consistent with the phenotypes of cells expressing a
translational fusion of ubiquitin to β-Arr2 (see above) and
provide an additional mechanism for the regulation of
arrestin function. Strikingly, recruitment of USP33 to β-Arr2
depends on the receptor class, in agreement with previous
finding that receptor class determines the kinetics of β-Arr2
deubiquitylation [36]. In addition, receptors belonging to the
same class can target diﬀerent lysine residues on β-Arr2 for
ubiquitylation [32]. Therefore, binding of β-Arr2 to diﬀerent
receptors may trigger distinct conformational change that
could modulate both ubiquitylation sites accessibility and
association with deubiquitylating enzymes, hence leading to
a diﬀerent functional output—in full support of the concept
of an “ubiquitylation code.”
6. Concluding Remarks
In this paper, we emphasized the many relationships between
ubiquitin metabolism and arrestin biology. Many proteins of
the arrestin family act as ubiquitin ligase adaptors and are
required for ubiquitylation of endocytic cargo. In particu-
lar, recent data obtained on arrestin-related proteins have
pointed out several features shared with β-arrestins, such as
the intimate connection existing between these proteins and
ubiquitin ligases of the Nedd4 family. In addition, ubiquitin
also regulates arrestin function in a yet undefined way, which
is now critical to understand. However, the emergence of new
regulatory mechanisms involving a now expanded family of
arrestin proteins, combined with the multiplicity of model
organisms, is likely to favor the rapid evolution of concepts
in arrestin biology.
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